Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine

FEMS Immunology and Medical Microbiology

Volumn 13, Issue 1, 1996, Pages 9-17

  Milagres, Lucimar G ^a   Brandileone, Maria Cristina C ^a   Sacchi, Claudio T ^a   Vieira, Vera S D ^a   Zanella, Rosemeire C ^a   Frasch, Carl E ^b  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Iron regulated protein; Lipooligosaccharide; Neisseria meningitidis; Outer membrane; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOGENICITY; MENINGITIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0030029289     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(95)00072-0     Document Type: Article

References (33)

1. Frasch, C.E. (1989) Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2 (suppl.), 134-138.
2. Bjune, G., Hoiby, E.E., Gronnesby, J.K., Arnesen, O., Fredriksen, J.H.O., Haltstensen, A., Holten, E., Lindbak, A.K., Nokleby, H., Rosenqvist, E., Solberg, L.K., Closs, O., Froholm, L.O., Lystad, A., Bakketeig, L.S. and Hareid, B. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093-1096.
3. R against disease caused by serogroup B Neisseria meningitidis. In: Neisseria 1990 (Atchtman, M. et al. Ed.), pp. 129-134.
4. Moraes, J.C., Perkins, B.A., Camargo, M.C.C., Hidalgo, N.T.R., Barbosa, H.A., Sacchi, C.T., Gral, I.M.L., Gattas, V.L., Vasconcelos, H.G., Plikaytis, B.D., Wenger, J.D. and Broome, C.V. (1992) Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340, 1074-1078.
5. Sacchi, C.T., Pessoa, L.L., Ramos, S.R., Milagres. L.G., Camargo, M.C., Hidalgo, N.T.R., Melles, C.E.A., Caugant, D.A. and Frasch, C.E. (1992) Ongoing group B Neisseria meningitidis eoidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J. Clin. Microbiol. 30, 1734-1738.
6. Camargo, M.C.C. and Hidalgo, N.T.R. (1989) Doença meningocócica: a vacina contra o meningococo B e a situação atual na Grande São Paulo. Imunizações 2, 161-167.
7. Zollinger, W.D. (1991) Meningococcal meningitis. In: Vaccine and Immunotherapy (Cryz S.J. Jr., Ed.), pp. 113-126.
8. Verheul, A.F.M., Snippe, H. and Poolman, J.T. (1993) Meningococcal lipopolysaccharide: virulence factor and potential vaccine component. Microbiol. Rev. 57, 34-49.
9. Saukkonen, K., Leinonen, M., Abdillahi and Poolman, J.T. (1989) Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vivo bactericidal assay. Vaccine 7, 325-328.
10. Bhatnagar, B.N. and Frasch, N.C.E. (1990) Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use in vaccines. Infect. Immun. 58, 2875-2881.
11. Ala'Aldeen, D.A., Wall, R.A. and Borriello, S.P. (1990) Immunogenicity and cross-reactivity of the 70-Kda iron-regulated protein of Neisseria meningitidis in man and animals. J. Med. Microbiol. 32, 273-281.
12. Ferron, L., Ferreiros, C.M., Criado, M.T. and Pintor, M. (1992) Immumogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis. Infect. Immun. 60, 2887-2892.
13. Criado, MT., Pintor, M. and Ferreirós, C.M. (1993) Iron uptake by Neisseria meningitidis. Res. Microbiol. 144, 77-82.
14. Martel, N. and Lee, B.C. (1994) Acquisition of heme iron by Neisseria meningitidis does not involve meningococcal transferrin-binding proteins. Infect. Immunn. 62, 700-703.
15. Frasch, C.E. (1990) Production and control of Neisseria meningitidis vaccines. In: Bacterial vaccines (Mizrahi, A. Ed.), pp. 123-145.
16. Lowry, O.H., Rosebrough, J.N., Farr. A.L. and Randall, R.J. (1951) Protein measurement with the folin phenol reagents. J. Biol. Chem. 193, 265-275.
17. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
18. Warren, L. (1959) The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234, 1971-1975.
19. Osborn, M.J., Gander, J.E., Parisi, E. and Carson, J. (1972) Mechanism of assembly of the outer membrane of Salmonella typhimurium. J. Biol. Chem. 247, 3962-3972.
20. Gu, X.-X. and Tsai, C.-M. (1991) Purification of rough-type lipopolysaccharide of Neisseria meningitidis from cells and membrane vesicles in spent media. Anal. Biochem. 196, 311-318.
21. Delvig A.A., Krasnoproshina, L.I., Kuvakina, V.I. and Dmitriev, B.A. (1991) Protective activity of detoixified lipooligosaccharides of Neisseria meningitidis serogroups A and B in mice. In: Neisseria 1990 (Achtman, M., Kohl, P., Marchai, C., Morelli, G., Sieler, A. and Thiesen, B., Eds.), Walter de Gruyter, Berlin, pp. 331-335.
22. Hochstein, H.D. (1985) government, U.S. quality control program for Limulus amebocyte lysate and endotoxin. In: Bacterial Endotoxins: Structure. Biochemical Significance and Detection with Limulus Amebocyte Lysate Test (Gate, J. et al.. Eds.), Alan R. Liss, New York, pp. 221-239.
23. US Pharmacopoeia XX. (1980) Pryogen Test, The United States Pharmacopoeial Convention, Rockville, MD, pp. 902-903.
24. Fredriksen, J.H., Rosenqvist, E., Wedege, E., Bryn, K., Bjune, G., Froholm, L.O., Lindbak, A.-K., Mogster, B., Namork, E., Rye, U., Stabbetorp, G., Winsnes, R., Aase, B. and Closs, O. (1991) Production, characterization and control of MenB-vaccine 'folkehelsa': an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Annals 14, 67-80.
25. Harthug, S., Rosenqvist, E., Hoiby, E.A., Gedde, T.W.-Dahl and Froholm, L.O. (1986) Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. J. Clin. Microbiol. 24, 947-953.
26. Anderson, E.L., Bowers, T., Mink, C.M., Kennedy, D.J., Belshe, R.B., Harakeh, H., Pais, L., Holder, P. and Carlone, G.M. (1994) Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect. Immun. 62, 3391-3395.
27. Wedege, E. and Froholm, L.O. (1986) Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect. Immun. 51, 571-578.
28. Mietzner, T.A., Bolan, G., Schoolnik, and, G.K. Morse, S.A. (1987) Purification and characterization of the major iron-regulated protein expressed by pathogenic Neisseria. J. Exp. Med. 165, 1041-1057.
29. Mandrell, R., Schneider, H., Apicella, M., Zollinger, W., Rice, P.A. and Griffis, M. (1986) Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharide. Infect. Immun. 54, 63-69.
30. Black, J.R., Dyer, D.W., Thompson, M.K. and Sparling, F. (1986) Human immune response to iron-repressible outer membrane proteins of N. meningitidis. Infect. Immun. 54, 710-713.
31. Ferreirós, C.M., Ferrón, L. and Criado, M.T. (1994) In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis. FEMS Immunol. Med. Microbiol. 8, 63-68.
32. Lissolo, L., Maitre-Wilmotte, G., Dumas, P., Mignon, M., Danve, B. and Quentin-Millet, M.-J. (1995) Evaluation of transferrin-binding protein 2 with the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect. Immun. 63, 884-890.
33. Aoun, L., Lavitola, A., Aubert, G., Prère, M.F., Cremieux, A.C. and Martin, P.M.V. (1998) Human antobody response to the 70-Kd common neisserial antigen in patients and carriers of meningococcal or non-pathogenic Neisseria. Ann. Inst. Pasteur 139, 203-212.